206 related articles for article (PubMed ID: 7095347)
1. [Massive, painful hepatomegaly, sinusoidal dilatation and prolonged use of estroprogestational agents].
Fischer D; Kémény F; Rauturseau J; Marty M; Karsenti P
Gastroenterol Clin Biol; 1982 Mar; 6(3):302-4. PubMed ID: 7095347
[No Abstract] [Full Text] [Related]
2. [Risks of postcoital contraception using a d-norgestrel-ethinyl estradiol combination].
Welti H; Nguyen Duy N; Zufferey MM
Ther Umsch; 1986 May; 43(5):438-40. PubMed ID: 3726780
[No Abstract] [Full Text] [Related]
3. [Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives].
Otero González A; Santos C; Jiménez JL; Gil J; Sánchez-Guisande D; Temes Montes XL
Med Clin (Barc); 1984 May; 82(18):824. PubMed ID: 6429463
[No Abstract] [Full Text] [Related]
4. Ultrasonography in the diagnosis and follow-up of hepatic sinusoidal dilatation.
Weinberger M; Garty M; Cohen M; Russo Y; Rosenfeld JB
Arch Intern Med; 1985 May; 145(5):927-9. PubMed ID: 3888136
[TBL] [Abstract][Full Text] [Related]
5. [A patient with a large liver tumor and long-term use of oral contraceptives].
Scheurlen C; Mannes GA; Sauerbruch T; Moser E
Internist (Berl); 1985 Dec; 26(12):789-93. PubMed ID: 3936820
[No Abstract] [Full Text] [Related]
6. Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids.
Winkler K; Poulsen H
Scand J Gastroenterol; 1975; 10(7):699-704. PubMed ID: 1188303
[TBL] [Abstract][Full Text] [Related]
7. Less estrogen in new oral contraceptive.
Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
[No Abstract] [Full Text] [Related]
8. Atypical reserve cell hyperplasia of cervical glands, simulating adenocarcinoma. An undescribed reversible lesion in a woman taking oral contraceptives.
Filotico M; Grasso S
Tumori; 1981 Oct; 67(5):491-6. PubMed ID: 7324178
[No Abstract] [Full Text] [Related]
9. [Role of tobacco and oral contraception in myocardial infarction in the female. Description of a case].
Leone A; Lopez M
Pathologica; 1984; 76(1044):493-8. PubMed ID: 6440110
[No Abstract] [Full Text] [Related]
10. [Use of Ovidon, Rigevidon and Postinor for contraception].
Kulakov VI; Barinov AM; Prilepskaia VN
Akush Ginekol (Mosk); 1983 Nov; (11):22-4. PubMed ID: 6666791
[No Abstract] [Full Text] [Related]
11. [Rigevidon and Ovidon in the therapy of menstrual cycle disorders].
Prilepskaia VN; Baklaenko NG; Chernaia VV
Akush Ginekol (Mosk); 1983 Nov; (11):24-7. PubMed ID: 6666792
[No Abstract] [Full Text] [Related]
12. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Christie T
J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
[No Abstract] [Full Text] [Related]
13. [Budd-Chiari syndrome after taking contraceptive drugs].
Goebell H; Dölle W
Dtsch Med Wochenschr; 1972 Nov; 97(44):1701-4. PubMed ID: 4639329
[No Abstract] [Full Text] [Related]
14. [Paget-Schroetter syndrome caused by the use of oral contraceptives].
Steiner A; Millei J; Ján H; Erös L
Orv Hetil; 1982 Sep; 123(39):2419-21. PubMed ID: 7145407
[No Abstract] [Full Text] [Related]
15. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose.
Karsay K
Ther Hung; 1980; 28(1):17-20. PubMed ID: 7281074
[TBL] [Abstract][Full Text] [Related]
16. Norgestimate: overview of a monophasic formulation.
Anderson FD; Gillmer MD
Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():126-32. PubMed ID: 8260971
[No Abstract] [Full Text] [Related]
17. [Effects of hormonal contraceptives on parameters of lipid metabolism (author's transl)].
Carol W; Klinger G
Zentralbl Gynakol; 1980; 102(22):1273-82. PubMed ID: 6164181
[TBL] [Abstract][Full Text] [Related]
18. Possible estrogen-induced NMS.
Rivera JM; Iriarte LM; Lozano F; Garcia-Bragado F; Salgado V; Grilo A
DICP; 1989 Oct; 23(10):811. PubMed ID: 2510410
[No Abstract] [Full Text] [Related]
19. [Estrogen-progestogen agents and megaloblastic anemia].
Mottier D; Jouquan J; Baccino E; Cleuziou A; Pennec Y; Kerlan V; Garo B; Bergeret G
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):707-10. PubMed ID: 6520357
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of some blood clotting parameters in relation to the administration of estroprogestins].
Orlandi F; Cattaneo C; Gabasio S; Spandre M; Paccotti P; Rustichelli S
Arch Sci Med (Torino); 1978; 135(4):609-17. PubMed ID: 756722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
